NTRK1 and nonpapillary renal cell carcinoma: Because ccRCC is intrinsically insensitive to radio- and chemotherapy, several novel treatment strategies have been applied, among which is multitargeted tyrosine-kinase receptor (TKR) inhibitors [5, 6].